<
XOLAIR 150MG OMALIZUMAB VIAL
Xolair is indicated as add-on therapy to improve asthma control in patients with severe persistent allergic asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and who have reduced lung function (FEV1 <80%) as well as frequent daytime symptoms or night-time awakenings and who have had multiple documented severe asthma exacerbations despite daily high-dose inhaled corticosteroids, plus a long-acting inhaled beta2-agonist.
KES 116,149.00
(Inclusive of all taxes)
-
Compare
-
Share:
-
No Warranty
-
COD Avilable
-
Non Returnable
-
Non cancelable
XOLAIR 150MG OMALIZUMAB VIAL
No FAQs Found
Related Products
